(Q51516709)

6 April 2018

title

Effect of the interleukin-6 (-174) g/c promoter polymorphism on adiponectin and insulin sensitivity. (English)

1 reference

6 April 2018

4

Markku Laakso

1 reference

6 April 2018

Xiaolin Yang

1

1 reference

6 April 2018

Per-Anders Jansson

series ordinal

2

1 reference

6 April 2018

Fredrik Pellmé

series ordinal

3

1 reference

6 April 2018

Ulf Smith

series ordinal

5

1 reference

6 April 2018

publication date

1 May 2005

1 reference

6 April 2018

published in

Obesity

1 reference

6 April 2018

volume

13

1 reference

6 April 2018

issue

5

1 reference

6 April 2018

page(s)

813-817

1 reference

6 April 2018

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.92

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.92

Interleukin-6 gene polymorphism and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.92

The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.92

The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.92

Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjögren's syndrome and correlate with the clinical manifestations of the disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.92

Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.92

Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.92

Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.92

High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.92

Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.92

Improved beta-cell function after standardized weight reduction in severely obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.92

Dual action of adiponectin on insulin secretion in insulin-resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.92

Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.92

Human Smad3 and Smad4 are sequence-specific transcription activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.92

Inhibition of E-selectin gene expression by transforming growth factor beta in endothelial cells involves coactivator integration of Smad and nuclear factor kappaB-mediated signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.92

Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.92

The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.92

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2005.92

1 reference

6 April 2018

PubMed ID

15919832

1 reference

6 April 2018